Completed PHASE2 INTERVENTIONAL 2-arm NCT04615754

Ketones for Pulmonary Hypertension - Effects on Hemodynamics (KEPAH)

Ketone Administration in Patients With Pulmonary Hypertension - Effects on Hemodynamics

Sponsor: Danish Heart Foundation

Conditions Ketonemia Pulmonary Hypertension

Interventions Hyperketonemia - use of ketone (3-OHB) infusion Placebo - use of saline infusion

Updated 5 times since 2020 Last updated: Dec 1, 2021 Started: Aug 18, 2020 Primary completion: May 1, 2021 Completion: Nov 29, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04615754, this PHASE2 trial focuses on Ketonemia and Pulmonary Hypertension and remains completed. Sponsored by Danish Heart Foundation, it has been updated 5 times since 2020, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2022 — Jul 2024 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2021 — Jan 2022 [monthly]

Recruiting PHASE2
Dec 2020 — Jan 2021 [monthly]

Recruiting PHASE2

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danish Heart Foundation
University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark